Related Experiment Video
Updated: May 17, 2026
06:26
Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
Published on: July 28, 2023
A rational vaccine pipeline for tuberculosis.
M J Brennan1, M R Stone, T Evans
1Global Affairs, Aeras, Rockville, Maryland 20850, USA. mbrennan@aeras.org
Summary
New tuberculosis (TB) vaccines are nearing clinical trials, but understanding TB pathogenesis and immune responses is crucial for developing effective vaccines. Establishing correlates of immunity will accelerate the approval and distribution of safe and effective TB vaccines globally.
Area of Science:
- * Vaccinology and immunology
- * Infectious disease research
- * Global public health
Background:
- * Tuberculosis (TB) vaccine development is at a critical juncture, with potential new vaccines progressing towards late-stage clinical trials.
- * Significant knowledge gaps persist regarding TB pathogenesis and the host immune responses necessary for protective immunity.
- * Existing TB vaccines have limitations, necessitating the development of novel, more effective candidates.
Purpose of the Study:
- * To highlight the current status and future prospects of tuberculosis vaccine development.
- * To identify key challenges in understanding TB pathogenesis and host immunity for vaccine design.
- * To emphasize the need for establishing correlates of vaccine immunity to facilitate regulatory approval and global deployment.
Main Methods:
- * Review of current landscape of TB vaccine research and development.
- * Analysis of existing challenges in TB pathogenesis and immunology research.
- * Discussion of the critical role of correlates of immunity in vaccine licensure.
Main Results:
- * Several new TB vaccine candidates are advancing, with potential for Phase III trials and licensure within the decade.
- * Understanding protective immune responses and TB pathogenesis remains a significant hurdle.
- * Establishing reliable correlates of vaccine immunity is essential for global TB vaccine accessibility.
Conclusions:
- * The development of safe and effective TB vaccines for all populations requires continued research and investment.
- * Bridging studies for TB vaccine approval hinge on identifying robust correlates of immunity.
- * Collaborative efforts and resources are vital to meet the global TB control community's ambitious goals.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...